KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Return on Equity (2016 - 2025)

Historic Return on Equity for Dynavax Technologies (DVAX) over the last 15 years, with Q3 2025 value amounting to 0.08%.

  • Dynavax Technologies' Return on Equity fell 1200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.04% for FY2024, which is 600.0% up from last year.
  • Latest data reveals that Dynavax Technologies reported Return on Equity of 0.08% as of Q3 2025, which was down 1200.0% from 0.1% recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Return on Equity peaked at 0.7% during Q3 2022, and registered a low of 0.49% during Q1 2021.
  • For the 5-year period, Dynavax Technologies' Return on Equity averaged around 0.14%, with its median value being 0.03% (2024).
  • As far as peak fluctuations go, Dynavax Technologies' Return on Equity surged by 126400bps in 2021, and later plummeted by -6000bps in 2023.
  • Over the past 5 years, Dynavax Technologies' Return on Equity (Quarter) stood at 0.69% in 2021, then dropped by -21bps to 0.54% in 2022, then plummeted by -102bps to 0.01% in 2023, then surged by 509bps to 0.04% in 2024, then plummeted by -297bps to 0.08% in 2025.
  • Its Return on Equity was 0.08% in Q3 2025, compared to 0.1% in Q2 2025 and 0.11% in Q1 2025.